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Aim: To study the use of RapidArc techniques in the treatment of prostate cancer patients
with hip prosthesis.
Background: An important aspect of treatment planning is to achieve dose homogeneity
inside the planning target volume (PTV). Especially for those patients presenting with hip
prosthesis, it becomes a challenging task to achieve dose uniformity inside the PTV.
Materials and methods: Five prostate patients presenting with hip prosthesis who had under-
gone radical radiotherapy were selected for this study. Depending on the composition of
prosthesis, a predeﬁned set of Hounsﬁeld values were assigned to each study set. Rapi-
dArc plans were generated on an Eclipse treatment planning system. Two  arcs that include
clockwise and counter-clockwise arcs were used in all these cases. To avoid beams passing
through the prosthesis, a simple structure was deﬁned around it with 1 cm margin and a
strict  dose constraint applied to the block during VMAT optimization.
Results: The mean D2/D98 ratio of PTV for all the patients was 1.06 ± 0.01. The mean percent-
age  rectum volume receiving 50 Gy, 60 Gy, 70 Gy and 75 Gy for all the patients were 33.1 ± 5.9,
21.7 ± 5.5, 13.8 ± 4.4 and 9.5 ± 3.0, respectively.
Conclusions: This study shows that using a double arc RapidArc technique is a simple andeffective treatment method of treating prostate cancer in patients presenting with a hip
prosthesis. The deﬁnition of a beam avoidance structure encompassing the prosthesis and
applying strict dose constraints to it reduces the beam contribution to the prosthesis
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the planning target volume with reduced dose to the sur-.  Backgroundigh dose radiotherapy has been shown to be an effective
reatment modality for prostate cancers.1–3 An important
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aspect of treatment planning is to achieve uniform dose insideCentre, Victoria, Australia. Tel.: +61 03 5454 9234;
kar smr@hotmail.com (R. Prabhakar).
rounding critical structures. Hip replacement is a surgical
procedure in which the hip joint is replaced by a prosthetic
implant. Prostheses are usually made of high density material
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such as titanium, steel, etc. High density material poses
signiﬁcant problem to the incident or exiting beam. These
materials not only attenuate the treatment beam but also
scatter the dose which may lead to dosimetric uncertainty
at the soft tissue interfaces. Hence, it becomes a challeng-
ing task to achieve dose uniformity inside the PTV for these
patients who  undergo radiotherapy. Besides, for those patients
with unknown prosthetic material, the chances of dosimetric
uncertainty are imminent. Even if the electron density of the
prosthesis is known, most dose calculation algorithms have
been designed and tested only for lower densities, and do
not accurately model the absorption and scattering proper-
ties of metals. The Treatment Planning System (TPS) is likely
to overestimate dose, particularly if the prosthesis is solid and
made of stainless steel or cobalt-chromium. However, several
dose calculation algorithms 4–7 have been developed over the
period of time that predict dose closer to Monte Carlo com-
puted dose for high density material. Another problem with
computed tomography (CT) scan images is the presence of
artifacts on images caused by prosthesis due to attenuation
of X-ray beam. Hence, it has become a standard practice to
avoid beams passing through these prosthetic materials.8 In
the midst of the above factors, there is a need to assess the
dosimetry for patients presenting with hip prosthesis with
advanced treatment techniques, such as volumetric modu-
lated radiotherapy (VMAT). Hence, in this study, an effort
has been made to demonstrate the use of volumetric mod-
ulated arc therapy for prostate patients presenting with hip
prosthesis.2.  Aim
To study the use of RapidArc technique in the treatment of
prostate cancer patients with hip prosthesis.
Table 1 – Dosimetric parameters for unilateral and bilateral hip
A B 
Bilateral Rt. Lateral 
PTV
Max. dose (%) 105.8 108.2 
D2 (cGy) 8010.0 7910.0 
D98 (cGy) 7496.0 7549.8 
Bladder
Max. dose (%) 105.8 105.6 
V70 (%) 20.0 7.3 
V50 (%) 31.1 14.3 
Rectum
V50 (%) 32.8 32.9 
V60 (%) 21.4 24.1 
V70 (%) 13.6 16.1 
V75 (%) 9.4 11.7 
Rt. femur
Mean dose (cGy) 384.1 606.0 
Max. dose (cGy) 2757.0 1333.0 
V10 (%) 16.1 0.0 
Lt. femur
Mean dose (cGy) 500.8 979.0 
Max. dose (cGy) 1742.6 3254.0 
V10 (%) 2.8 0.5 iotherapy 1 8 ( 2 0 1 3 ) 209–213
3.  Materials  and  methods
Five prostate patients who had undergone radical radiothe-
rapy were selected for this study. Of the ﬁve patients, four
had unilateral hip prosthesis and one patient presented with
bilateral hip prosthesis. All patients underwent CT scanning
on Philips Brilliance CT scanner and the Dicom CT datasets
were transferred to Eclipse treatment planning system (Varian
Medical System, USA) for contouring. The regions of dark and
bright streaking artifacts replacing the soft tissues present in
the CT images due the effect of kilovoltage beams on the pros-
thesis were contoured and Hounsﬁeld unit (HU) value of 0 was
assigned. Depending on the type of prosthesis, the following
Hounsﬁeld values were used during planning: Bone: 800 HU;
Titanium: 4500 HU; Co–Cr–Mo or stainless steel: 9500, respec-
tively. To those prosthesis whose composition is unknown,
7000 HU was assigned. The PTV was generated from clinical
target volume (CTV) on assigning a uniform margin of 1 cm in
all directions except for 0.7 cm along the posterior direction.
RapidArc plans were generated on Eclipse treatment planning
system. Two arcs that include clockwise and counter clock-
wise arcs were used in all these cases. To avoid beams passing
through prostheses, a simple structure known as beam avoid-
ance structure was generated around the prosthesis with a
1 cm margin and a strict dose constraint (0% of the volume
receives over 500 cGy) was applied to the block during volu-
metric modulated radiation therapy (VMAT) optimization to
avoid dose to the prosthesis. A dose of 78 Gy was prescribed to
all the patients with 95% of prescription dose covering 99%
of the target volume. Collimator was rotated to 30◦ for the
clockwise and 330◦ for the counter-clockwise arc. All RapidArc
plans were generated with photon beam energy of 6 MV from a
21iX linear accelerator (Varian Medical Systems, Palo, Alto, CA)
using Analytical Anisotropic Algorithm (AAA) dose calculation
algorithm.
 prostate patients.
C D E
Rt. Lateral Lt. Lateral Lt. Lateral
111.9 111.7 109.2
7987.0 7951.0 7971.0
7502.0 7517.0 7543.0
107.6 105.5 104.3
28.0 8.7 5.2
49.7 13.8 13.1
42.6 30.8 26.5
29.3 19.3 14.6
19.4 12.1 7.6
12.8 8.5 5.1
526.5 481.6 921.7
3690.0 3472.0 1995.0
4.6 5.8 46.0
965.9 522.5 483.0
3104.0 1932.0 973.0
40.3 5.8 0.0
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rFig. 1 – Dose distribution of a bilateral hip
.  Results
able 1 shows the dosimetric parameters for ﬁve prostate
atients selected in this study. Figs. 1 and 2 show the dose
istribution and the dose volume histogram of a bilateral hip
rosthesis for a double arc VMAT  technique. Fig. 1 illustrates
he use of the beam avoidance structure (green color contour)
round the femur deﬁned for reducing the beam contribution
o the prosthesis. Fig. 3 depicts the dose distribution of a uni-
ateral hip prosthesis for a double arc VMAT technique. No
olume of the right and left femur received dose greater than
5 Gy. The mean D2/D98 (D2: near maximum absorbed dose
hat covers 2% of the volume; D98: near minimum absorbed
ose that covers 98% of the volume) ratio of PTV for all the
atients was 1.06 ± 0.01. The mean percentage rectum volume
eceiving 50 Gy (V50), 60 Gy (V60), 70 Gy (V70), 75 Gy (V75) for all
Fig. 2 – Dose volume histogramsthesis for a double arc VMAT  technique.
the patients was 33.1 ± 5.9, 21.7 ± 5.5, 13.8 ± 4.4 and 9.5 ± 3.0,
respectively. The mean bladder volume receiving 70 Gy (V70)
and 60 Gy (V60) for all the studied patients was 13.8 ± 9.8% and
24.4 ± 16.0%, respectively. For the right femur, the mean dose,
and volume receiving 10 Gy (V10) for patients with bilateral
and right hip prosthesis was 500.5 ± 112.4 cGy and 6.90 ± 8.3%
respectively. Similarly for the left femur, the mean does and
V10 for bilateral and patients with left hip prosthesis was
502.1 ± 19.8 cGy and 2.87 ± 2.9%, respectively.
5.  DiscussionIntensity modulated radiation therapy is currently the
standard treatment technique used in the treatment of
prostate cancer with metal hip prosthesis.9,10 Different forms
of beam arrangements have been proposed for unilateral
 of a bilateral prosthesis.
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p proFig. 3 – Dose distribution of a unilateral hi
and bilateral prostheses using intensity modulated radiation
therapy (IMRT) that includes coplanar11 and non-coplanar
beam arrangements.12 Although, it has been found to pro-
duce acceptable target volume coverage for most of the clinical
situations in prostate cancer involving prostheses, it is still
regarded as a challenging task in treatment planning due to
the prectal volume overlapping PTV. The presence of metal
prostheses leads to artifacts on CT images and poses a chal-
lenge in deﬁning the organs at risk and target volumes on
kilovoltage CT. These artifacts have a signiﬁcant impact of up
to 70% on the Hounsﬁeld values for nearby and distant struc-
tures on the transverse slice.13 The quality of CT images can
also be improved with artifact-suppressing algorithms.14,15
Another simpler and elegant way of tackling these metal arti-
facts is the use of megavoltage CT images. The megavoltage
CT scanners minimize artifacts as compared to kilovoltage
CT scanners and such megavoltage images are more  useful
for delineating the target and critical structures.13 One such
megavoltage scanner is the helical tomotherapy that provides
a remarkable trend in radiotherapy by providing megavolt-
age images for contouring, treatment planning and treatment
veriﬁcation.16 Meeks et al.17 demonstrated that the uniformity
and spatial resolution of megavoltage CT (MVCT) images gen-
erated by Hi-Art II tomotherapy were comparable to diagnostic
CT images; however; they do not have the same performance
characteristics as diagnostic CT images.
An increase in dose at the bone-metal interface may lead to
bone necrosis and weakening of the implant ﬁxation. To date,
there are no quantitative data available on the effects of the
increased dose at the interface between a hip prosthesis and
surrounding tissue in patients undergoing radical treatment of
tumors in the pelvic region. It has been shown by Keall et al.18
that the interface between the prostate and the prosthesis did
not affect the dose to the target due to a sufﬁcient gap between
them. Monte Carlo treatment planning systems are shown to
19predict accurate doses at the tissue-prosthesis interface.
Our study presents a simple and effective treatment
method using RapidArc technique for patients presenting
with hip prosthesis. It clearly illustrates that the use ofsthesis for a double arc VMAT technique.
a beam avoidance structure contoured around the pros-
thesis and assigning a strict dose constraint during the
optimization process helps in restricting the dose from beams
passing through prostheses resulting in a uniform dose to
PTV complying with the dose to critical structures. The
technique can be used for all unilateral and bilateral hip
prostheses. The planning is quite simple and straightfor-
ward unlike in IMRT which requires multiple runs to achieve
an acceptable dose distribution. VMAT  is currently evolv-
ing as the most popular treatment modality due to shorter
time20 required to deliver treatment as compared to con-
ventional 3D conformal radiotherapy and IMRT  technique.
This may also reduce a possible uncertainty in dose due
to a setup error. The treatment of prostate patients treated
in prone position tends to reduce the dose to organs at
risk21 as compared to supine position which needs further
study in the case of patients presenting with hip prosthe-
sis.
6.  Conclusion
This study shows that RapidArc technique with double arcs is
a simple and effective treatment method in case of patients
presenting with hip prosthesis. The use of a beam avoidance
structure encompassing the prosthesis and applying strict
dose constraints reduces the beam contribution to the pros-
thesis.
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